Scynexis (SCYX) Other Non Operating Income (2014 - 2026)

Scynexis (SCYX) posted Other Non Operating Income of $354000.0 for Q1 2026, up 1164.29% on a QoQ basis from $28000.0 in Q2 2024.

Scynexis (SCYX) Other Non Operating Income (2014 - 2026) Analysis & Trends

Scynexis' Other Non Operating Income history runs 8 years deep, the most recent figure standing at $354000.0 for Q1 2026.

  • Quarterly Other Non Operating Income changed N/A year-over-year to $354000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $354000.0 (up 1164.29% YoY) and the FY2024 annual result came in at $196000.0, up 853.85% from the prior year.
  • Other Non Operating Income was $354000.0 for Q1 2026 at Scynexis, up from $28000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $354000.0 in Q1 2026 and bottomed at -$1.1 million in Q4 2022.
  • A 4-year average of -$62200.0 and a median of $35000.0 in 2023 frame the typical range for Other Non Operating Income.
  • Peak annual rise in Other Non Operating Income reached 533.33% in 2023, while the deepest fall reached 3223.08% in 2023.
  • Scynexis' Other Non Operating Income stood at -$1.1 million in 2022, then jumped by 113.97% to $156000.0 in 2023, then plunged by 82.05% to $28000.0 in 2024, then jumped by 1164.29% to $354000.0 in 2026.
  • Business Quant data shows SCYX's Other Non Operating Income at $354000.0 in Q1 2026, $28000.0 in Q2 2024, and $168000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Scynexis 21.55 Mn -15.20 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 354,000.00
Jun 30, 2024 28,000.00
Mar 31, 2024 168,000.00
Dec 31, 2023 156,000.00
Sep 30, 2023 182,000.00
Jun 30, 2023 42,000.00
Mar 31, 2023 -406,000.00
Dec 31, 2022 -1.12 Mn
Sep 30, 2022 -42,000.00
Mar 31, 2022 13,000.00
Dec 31, 2021 -1.66 Mn
Jun 30, 2021 462,000.00
Dec 31, 2020 1.00 Mn
Sep 30, 2020 5.29 Mn
Jun 30, 2020 -806,000.00
Sep 30, 2019 2.32 Mn
Jun 30, 2019 -231,000.00
Mar 31, 2019 -800,000.00
Dec 31, 2014 1.38 Mn
Jun 30, 2014 -1.39 Mn